Romano Brothers & Co’s Avanos Medical AVNS Stock Holding History

Romano Brothers & Co’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-830	Closed	-$22.5K	–	347
2022 Q4	$22.5K	Buy	+830	New	+$20.3K	﹤0.01%	600

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Romano Brothers & Co's AVNS Position: Q1 2023 in Review

Romano Brothers & Co sold out of Avanos Medical (AVNS) in Q1 2023, closing a stake of 830 shares — an estimated $22.5K sold.

Romano Brothers & Co first reported a position in AVNS in Q4 2022 and held it in 1 quarter. The position peaked at $22.5K in Q4 2022. 287 funds tracked by Wall St. Rank hold AVNS as of Q1 2023.

Romano Brothers & Co reported no remaining Avanos Medical position as of Q1 2023 after selling out during the quarter.
Romano Brothers & Co sold 830 Avanos Medical shares in Q1 2023, an estimated $22.5K.
Romano Brothers & Co first reported a position in Avanos Medical in Q4 2022 and held it in 1 quarter.
Romano Brothers & Co's Avanos Medical position peaked at $22.5K in Q4 2022.
287 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2023.

Based on Romano Brothers & Co's 13F filing for Q1 2023, filed 13 Apr 2023.